The Mark H. Zangmeister Center-Mid Ohio Oncology/Hematology, Inc. — Columbus, Ohio

The Mark H. Zangmeister Center-Mid Ohio Oncology/Hematology, Inc. is a clinical research site located in Columbus, Ohio, United States 43219.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

The Mark H. Zangmeister Center-Mid Ohio Oncology/Hematology, Inc. has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Advanced Breast Cancer.

Sponsors: TerSera Therapeutics LLC.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Columbus

Browse all research sites in Ohio · View every site in Columbus

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for The Mark H. Zangmeister Center-Mid Ohio Oncology/Hematology, Inc.?

The Mark H. Zangmeister Center-Mid Ohio Oncology/Hematology, Inc. has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has The Mark H. Zangmeister Center-Mid Ohio Oncology/Hematology, Inc. conducted?

The Mark H. Zangmeister Center-Mid Ohio Oncology/Hematology, Inc. has 1 clinical trials on record, with 1 currently active. Their work covers Advanced Breast Cancer.

Is The Mark H. Zangmeister Center-Mid Ohio Oncology/Hematology, Inc. accredited by Crixeo Clinical Trials?

The Mark H. Zangmeister Center-Mid Ohio Oncology/Hematology, Inc. has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about The Mark H. Zangmeister Center-Mid Ohio Oncology/Hematology, Inc.?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.